Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Renner

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Cancer Immunity|March 10, 2009
Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8Stefan Bauer, Nicole Adrian, Uta Siebenborn, et al.
Leukemia & Lymphoma|August 22, 2018
Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantationCéline M Mürner, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Anticancer Research|October 4, 2011
Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1Anita Luethy, Frank Stenner, Corinne Lohri, et al.
Cancer Medicine|January 24, 2013
MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphomaWiyada Kwanhian, Dido Lenze, Julia Alles, et al.
Journal of Translational Medicine|August 14, 2013
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cellsPetra C Schuberth, Christian Hagedorn, Shawn M Jensen, et al.
Swiss Medical Weekly|December 5, 2015
Use of inpatient rehabilitation for cancer patients in Switzerland: who undergoes cancer rehabilitation?Maria Ture, Jürgen Barth, Felix Angst, et al.
European Journal of Immunology|June 15, 2007
MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processingGerhard Held, Andreas Wadle, Nina Dauth, et al.
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
European Journal of Immunology|September 16, 2004
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragmentsGerhard Held, Mitsutoshi Matsuo, Malka Epel, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Cancer Immunity|March 10, 2009
Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8Stefan Bauer, Nicole Adrian, Uta Siebenborn, et al.
Leukemia & Lymphoma|August 22, 2018
Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantationCéline M Mürner, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Anticancer Research|October 4, 2011
Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1Anita Luethy, Frank Stenner, Corinne Lohri, et al.
Cancer Medicine|January 24, 2013
MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphomaWiyada Kwanhian, Dido Lenze, Julia Alles, et al.
Journal of Translational Medicine|August 14, 2013
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cellsPetra C Schuberth, Christian Hagedorn, Shawn M Jensen, et al.
Swiss Medical Weekly|December 5, 2015
Use of inpatient rehabilitation for cancer patients in Switzerland: who undergoes cancer rehabilitation?Maria Ture, Jürgen Barth, Felix Angst, et al.
European Journal of Immunology|June 15, 2007
MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processingGerhard Held, Andreas Wadle, Nina Dauth, et al.
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
European Journal of Immunology|September 16, 2004
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragmentsGerhard Held, Mitsutoshi Matsuo, Malka Epel, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Pageof 13